Your institution may have access to this item. Find your institution then sign in to continue.
Title
Tinzaparin sodium: renal impairment in elderly.
Abstract
The article reports on a 2010 decision which the manufacturer of the low molecular weight heparin drug tinzaparin sodium made to inform health care professionals of a clinical study that was stopped after increased mortality was observed with use of the drug.